A2oz

What is the new antipsychotic in 2024?

Published in Medical 2 mins read

There is no single new antipsychotic drug specifically released in 2024. Pharmaceutical research and development is an ongoing process, and new medications take years to be researched, tested, and approved for public use.

However, there are several promising antipsychotic candidates currently undergoing clinical trials. Some of these drugs may be approved for use in the coming years, potentially impacting the treatment of mental health conditions.

Here are some potential future antipsychotics:

  • Lurasidone (Latuda): While already approved, research continues to explore its potential in treating different aspects of schizophrenia and other mental health conditions.
  • Cariprazine (Vraylar): This medication is currently used for schizophrenia and bipolar disorder, but further research may lead to expanded applications.
  • Brexpiprazole (Rexulti): This drug is currently approved for schizophrenia and major depressive disorder, but new research is exploring its potential for other conditions.

Note: The availability and approval of these or any other new antipsychotics may vary depending on geographical location and regulatory approvals. It is essential to consult with a qualified healthcare professional for accurate and up-to-date information on available treatments.

Related Articles